Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
180
archived clinical trials in
Hair Loss

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
mi
from
Lynchburg, VA
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated:  12/31/1969
mi
from
Norfolk, VA
ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Status: Enrolling
Updated: 12/31/1969
Aclaris Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated:  12/31/1969
mi
from
San Diego, CA
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
Phase 1, Randomized, Double-Blind, Vehicle-Controlled Study of Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Subjects With Female Pattern Hair Loss
Status: Enrolling
Updated: 12/31/1969
Cosmetic Laser Dermatology
mi
from
San Diego, CA
Click here to add this to my saved trials
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated:  12/2/2008
mi
from
Tucson, AZ
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated:  12/2/2008
mi
from
Philadelphia, PA
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
Phase II Double-Blind, Placebo-Controlled Study of the Safety and Preliminary Effectiveness of MTS-01 for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
Status: Enrolling
Updated: 12/2/2008
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated:  4/27/2010
mi
from
Mitchellville, MD
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in Alopecia
Safety and Efficacy of Clobetasol Propionate 0.05% E Foam in the Treatment of Central Centrifugal Cicatricial Alopecia
Status: Enrolling
Updated: 4/27/2010
Callender Center for Clinical Research
mi
from
Mitchellville, MD
Click here to add this to my saved trials
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated:  5/16/2012
mi
from
New York, NY
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)
Status: Enrolling
Updated: 5/16/2012
New York Eye and Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Santa Clara, CA
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Childhood Alopecia Areata Study: Part 1: Feasibility of the 308-nm Excimer Laser in Treatment of Patch Type Alopecia Areata in Pediatric Patients
Status: Enrolling
Updated:  11/21/2012
mi
from
Phoenix, AZ
Childhood Alopecia Areata Study Using the 308-nm Excimer Laser
Childhood Alopecia Areata Study: Part 1: Feasibility of the 308-nm Excimer Laser in Treatment of Patch Type Alopecia Areata in Pediatric Patients
Status: Enrolling
Updated: 11/21/2012
Phoenix Children's Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Alopecia Areata Registry and Immunogenetic Mechanisms
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  11/20/2013
mi
from
Minneapolis, MN
Alopecia Areata Registry and Immunogenetic Mechanisms
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 11/20/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Vytorin in the Treatment of Alopecia Areata
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated:  7/30/2014
mi
from
Miami, FL
Vytorin in the Treatment of Alopecia Areata
A Pilot Study To Evaluate the Efficacy of Vytorin (Simvastatin +Ezetimibe) In the Treatment of Alopecia Areata
Status: Enrolling
Updated: 7/30/2014
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Status: Enrolling
Updated:  1/26/2016
mi
from
New York, NY
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata
Status: Enrolling
Updated: 1/26/2016
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
mi
from
Fridley, MN
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Safety and Efficacy of Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Status: Enrolling
Updated:  3/31/2016
mi
from
Minneapolis, MN
Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Safety and Efficacy of Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata
Status: Enrolling
Updated: 3/31/2016
University of Minnesota-Department of Dermatology
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Efficacy of Topical Bimatoprost in Promoting Hair Growth in the Region of the Eyebrow and Eyelashes for Post-chemotherapy Patients Versus Normal Patients
Status: Enrolling
Updated:  4/6/2016
mi
from
Los Angeles, CA
Bimatoprost Ophthalmic Solution in Increasing Eyebrow and Eyelash Growth in Patients Who Have Undergone Chemotherapy for Breast Cancer and in Healthy Participants
Efficacy of Topical Bimatoprost in Promoting Hair Growth in the Region of the Eyebrow and Eyelashes for Post-chemotherapy Patients Versus Normal Patients
Status: Enrolling
Updated: 4/6/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  10/27/2016
mi
from
New York, NY
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
An Open-Label Pilot Study to Evaluate the Efficacy of Ruxolitinib in Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 10/27/2016
Columbia University Medical Center / Department of Dermatology
mi
from
New York, NY
Click here to add this to my saved trials
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated:  1/23/2017
mi
from
Bronx, NY
Yoga-Based Rehabilitation Program in Reducing Physical and Emotional Side Effects in Patients With Cancer
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Status: Enrolling
Updated: 1/23/2017
Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Status: Enrolling
Updated:  2/14/2017
mi
from
New York, NY
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
An Open-Label Pilot Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Status: Enrolling
Updated: 2/14/2017
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Feasibility Clinical Study of Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Status: Enrolling
Updated:  2/27/2017
mi
from
Rochester, NY
Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Feasibility Clinical Study of Compression Headband Use to Prevent Hair Loss During Whole Brain Radiotherapy
Status: Enrolling
Updated: 2/27/2017
Dept. of Radiation Oncology, University of Rochester, Med Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated:  10/4/2017
mi
from
Stanford, CA
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Tofacitinib for the Treatment of Alopecia Areata and Its Variants
Status: Enrolling
Updated: 10/4/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study of Secukinumab for the Treatment of Alopecia Areata
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
Status: Enrolling
Updated:  11/2/2017
mi
from
New York, NY
A Study of Secukinumab for the Treatment of Alopecia Areata
An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata
Status: Enrolling
Updated: 11/2/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Alefacept in Patients With Severe Scalp Alopecia Areata
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata
Status: Enrolling
Updated:  11/22/2017
mi
from
Minneapolis, MN
Alefacept in Patients With Severe Scalp Alopecia Areata
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center Study to Evaluate The Safety and Therapeutic Efficacy of Intramuscular Administration of Alefacept in Patients With Chronic, Severe Scalp Alopecia Areata
Status: Enrolling
Updated: 11/22/2017
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated:  1/16/2018
mi
from
New York, NY
Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
A Randomized Placebo-controlled Single Center Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
Status: Enrolling
Updated: 1/16/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
mi
from
San Francisco, CA
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
mi
from
Aurora, CO
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
University of Colorado - UCHSC - Health Science Center at Fitzsimons
mi
from
Aurora, CO
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
mi
from
Minneapolis, MN
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
mi
from
New York, NY
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated:  2/15/2018
mi
from
Houston, TX
Alopecia Areata Registry
Alopecia Areata Registry and Immunogenetic Mechanisms
Status: Enrolling
Updated: 2/15/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials